Literature DB >> 17367230

The prevalence of polyp in colon of patients with acromegaly.

Bagher Larijani1, Rasool Aliannejad, Nasibeh Khaleghnejad-Tabari, Reza Baradar-Jalili, Reza Ansari, Seyed-Mohammad Tavangar, Fatemeh Bandarian.   

Abstract

Several studies have shown that patients with acromegaly are at increased risk of developing colorectal polyps and cancer. The prevalence of polyp in colon of patients with acromegaly was variously reported between 23% and 53%. This study was conducted to determine the prevalence of polyp and cancer of colon in patients with acromegaly. Twenty-three patients with acromegaly were evaluated with colonoscopy for the presence of colonic polyps and cancer. Three patients were found to have colonic polyps. This translates to a prevalence rate of 13%. We recommend that screening colonoscopy be carried out once every three years in all acromegalic patients over the age of 40 years.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17367230     DOI: 07102/AIM.0019

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  4 in total

1.  Colonic neoplasia in acromegaly: increased proliferation or deceased apoptosis?

Authors:  Pinaki Dutta; Anil Bhansali; Kim Vaiphei; Usha Dutta; P Ravi Kumar; Shariq Masoodi; Kanchan Kumar Mukherjee; Alka Varma; R Kochhar
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

2.  Guidelines versus real life practice: the case of colonoscopy in acromegaly.

Authors:  M Parolin; F Dassie; L Russo; S Mazzocut; M Ferrata; E De Carlo; R Mioni; F Fallo; R Vettor; C Martini; P Maffei
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

3.  Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis.

Authors:  Theodoros Rokkas; Dimitrios Pistiolas; Panos Sechopoulos; Georgios Margantinis; Georgios Koukoulis
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

4.  Risk of neoplasms in acromegaly.

Authors:  Marek Ruchała; Ewelina Szczepanek-Parulska; Maciej Fularz; Kosma Woliński
Journal:  Contemp Oncol (Pozn)       Date:  2012-05-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.